A Clinical Study to Evaluate Enlicitide (MK-0616) Formulations in Healthy Adult Participants (MK-0616-035)

Completed · Phase 1

Conditions studied: Healthy

In brief

The goal of the study is to learn what happens to different forms of enlicitide medications in a healthy person's body over time. Researchers will compare the amount of enlicitide in the healthy person's body over time when enlicitide is given in different formulations.

Key facts

Study ID

NCT06880874

Run by

Merck Sharp & Dohme LLC

People needed

40

Starts

2025-04-02

Expected to finish

2025-05-31

Last updated by the study team

2025-06-15

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• The main inclusion criteria include but are not limited to the following:
• Continuous non-smoker who has not used nicotine- and tobacco-containing products for at least 3 months prior
• Has body mass index (BMI) ≥18 kg/m\^2 and ≤32 kg/m\^2

You may not qualify if…

• The main exclusion criteria include but are not limited to the following:
• Has history of gastrointestinal disease which may affect food and drug absorption or has had a gastric bypass or similar surgery
• Has history of cancer (malignancy)
• Has positive results for human immunodeficiency virus (HIV), hepatitis B surface antigen (HBsAg), or hepatitis C virus (HCV)

Where it is running

• Celerion ( Site 0001) — Tempe, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.